#United States #New York #Securities Fraud #Pomerantz LLP #Nano-X Imaging

Pomerantz Law Firm Investigates Nano-X Imaging Ltd.

On May 21, 2026, it was announced that Pomerantz LLP, a well-known law firm specializing in corporate and securities class actions, has initiated an investigation into Nano-X Imaging Ltd. (NASDAQ: NNOX) on behalf of investors. The firm is looking into potential securities fraud claims against the company and its key executives, amid growing concerns about the company's recent financial disclosures and corporate governance practices.

Following the release of financial results for the fourth quarter of 2025, Nano-X reported a staggering net loss of $33.4 million, a decline attributed mostly to a $17.5 million charge stemming from impairment of long-lived assets linked to a restructuring effort at its Korean chip manufacturing facility. This financial downturn has raised alarms among investors and prompted Pomerantz to act on their behalf. The investigation focuses on whether there was any wrongdoing or illegal business conduct by Nano-X or its executive team, which may have resulted in misleading investors about the company’s financial health.

This announcement of dire financial results, combined with the announcement that CFO Ran Daniel would be resigning from his position by July 31, 2026, led to a significant drop in Nano-X's stock price. On the day of the announcement, shares plummeted by 24.39%, closing at $2.16—a stark indication of investor sentiment and concern regarding the company’s future and management integrity.

Pomerantz LLP has a long and respected history in fighting for the rights of shareholders. Founded by Abraham L. Pomerantz, a pivotal figure in the development of class action lawsuits, the firm has secured numerous multimillion-dollar settlements for affected investors in the realms of securities fraud and corporate misconduct. Their reputation underscores the seriousness of the investigation into Nano-X and signals to investors the potential for recourse if they were misled.

Potential class members affected by the financial disclosures and subsequent stock price decline are encouraged to reach out to Pomerantz for more information on how to participate in the investigation. The firm is well-known for its success in similar cases and is poised to navigate the legal complexities that may arise as this situation develops.

Investors and market analysts will be watching closely as further information from the investigation becomes available. This case could potentially bring to light not only the actions of Nano-X but also serve as a cautionary tale for corporate governance and accountability in the rapidly evolving tech and imaging industries.

In summary, the investigation launched by Pomerantz LLP against Nano-X Imaging highlights significant concerns over corporate practices and investor protection, which will undoubtedly resonate across the securities market as stakeholders call for greater transparency. Investors who believe they may have suffered losses due to fraudulent activities are advised to seek legal counsel and consider joining the investigation to safeguard their rights as stakeholders of Nano-X Imaging Ltd.